Galderma Group AG
SIX:GALD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Galderma Group AG
SIX:GALD
|
CH |
|
Sunrise New Energy Co Ltd
NASDAQ:EPOW
|
CN |
|
Cadeler A/S
OSE:CADLR
|
DK |
|
Rupert Resources Ltd
XTSX:RUP
|
CA |
|
S
|
Sermsang Power Corporation PCL
SET:SSP
|
TH |
|
Capitol Health Ltd
ASX:CAJ
|
AU |
|
Applied Therapeutics Inc
NASDAQ:APLT
|
US |
Wall St Price Targets
GALD Price Targets Summary
Galderma Group AG
According to Wall Street analysts, the average 1-year price target for GALD is 191.48 CHF with a low forecast of 152.26 CHF and a high forecast of 273 CHF.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GALD's stock price target?
Price Target
191.48
CHF
According to Wall Street analysts, the average 1-year price target for GALD is 191.48 CHF with a low forecast of 152.26 CHF and a high forecast of 273 CHF.
What is the Revenue forecast for Galderma Group AG?
Projected CAGR
18%
Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 18%.
What is the Gross Profit forecast for Galderma Group AG?
Projected CAGR
19%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Galderma Group AG?
Projected CAGR
37%
Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 3 years is 37%.
What is the Pre-Tax Income forecast for Galderma Group AG?
Projected CAGR
55%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 55%.
What is the Net Income forecast for Galderma Group AG?
Projected CAGR
47%
The compound annual growth rate for Net Income over the next 3 years is 47%.
